Pharma Inc agrees to cap margins on non-price control drugs at 30%

A consensus to this effect was reached at a meeting held on Friday
between the drug pricing regulator, pharma lobby groups and industry
associations, said people present at the meeting. The 30% cap on trade
margins was preferred over other proposals such as imposing a flat
100% trade margin on all medicines, including those within price
control.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pharma-inc-agrees-to-cap-margins-on-non-price-control-drugs-at-30/articleshow/72251288.cms